Alnara Pharmaceuticals: Thomas Rowland new vice president
Mr. Rowland brings to Alnara significant pharmaceutical experience in the areas of marketing, sales and commercial operations, including several successful new product launches. Mr. Rowland served as vice president of the gastroenterology and women’s health business unit at Solvay Pharmaceuticals, where he oversaw all commercial operations for more than $250 million of product sales, including Solvay’s branded PERT.
Mr. Rowland's initial work in the gastroenterology and pancreatic enzyme therapeutic area started when he joined Scandipharm as director of marketing to assist in the company's turnaround, which resulted in the sale of the company to Axcan Pharmaceuticals. Prior to joining Alnara, Mr. Rowland was president, chief executive officer and director of Ventrus Biosciences, a specialty pharmaceutical company. ■